BORORENEWNSENovember 14, 2019

BOROSIL RENEWABLES LIMITED

1,131words
24turns
0analyst exchanges
0executives
Key numbers — 28 extracted
rs,
mited Corporate Relationship Department 151 Floor, New Trading Ring, Rotunda Building, P. J. Towers, Dalal Street, Mumbai - 400 001 Dear Sir /Madam, National Stock Exchange of India Ltd Exchange
9.4%
350.0 68.7 21.4 90.1 90.4 69.9 160.3 75.1 21.0 96.1 133.5 74.0 207.5 , , , 9.4% -2.3% 6.6% 47.7% 5.8% 29.4% BOROS II: 3 BOROS II: EBITDA from OQerations - BGWL * -
2.3%
68.7 21.4 90.1 90.4 69.9 160.3 75.1 21.0 96.1 133.5 74.0 207.5 , , , 9.4% -2.3% 6.6% 47.7% 5.8% 29.4% BOROS II: 3 BOROS II: EBITDA from OQerations - BGWL * - Larah
6.6%
21.4 90.1 90.4 69.9 160.3 75.1 21.0 96.1 133.5 74.0 207.5 , , , 9.4% -2.3% 6.6% 47.7% 5.8% 29.4% BOROS II: 3 BOROS II: EBITDA from OQerations - BGWL * - Larah - Kla
47.7%
90.1 90.4 69.9 160.3 75.1 21.0 96.1 133.5 74.0 207.5 , , , 9.4% -2.3% 6.6% 47.7% 5.8% 29.4% BOROS II: 3 BOROS II: EBITDA from OQerations - BGWL * - Larah - Klasspack
5.8%
90.4 69.9 160.3 75.1 21.0 96.1 133.5 74.0 207.5 , , , 9.4% -2.3% 6.6% 47.7% 5.8% 29.4% BOROS II: 3 BOROS II: EBITDA from OQerations - BGWL * - Larah - Klasspack 51.0
29.4%
69.9 160.3 75.1 21.0 96.1 133.5 74.0 207.5 , , , 9.4% -2.3% 6.6% 47.7% 5.8% 29.4% BOROS II: 3 BOROS II: EBITDA from OQerations - BGWL * - Larah - Klasspack 51.0 26.7
14.7%
: 3 BOROS II: EBITDA from OQerations - BGWL * - Larah - Klasspack 51.0 26.7 2.7 80.3 14.7% PAT (Including Income from Investments} 57 .7 - BGWL -3 .3 - Larah -1.8 - Klasspack 52.7
14.4%
from Investments} 57 .7 - BGWL -3 .3 - Larah -1.8 - Klasspack 52.7 21.7 13.4 1.0 36.1 14.4% 27 .7 -1.0 -1.2 25.5 26.9 19.3 1.6 47.8 15.7% 32.4 3 .2 -0.8 34.8 23 .8 % 44.5 %
15.7%
- Klasspack 52.7 21.7 13.4 1.0 36.1 14.4% 27 .7 -1.0 -1.2 25.5 26.9 19.3 1.6 47.8 15.7% 32.4 3 .2 -0.8 34.8 23 .8 % 44.5 % 53 .9 % 32.3% ... 1 7 .0 % 36.4% EBITDA as per
8 %
36.1 14.4% 27 .7 -1.0 -1.2 25.5 26.9 19.3 1.6 47.8 15.7% 32.4 3 .2 -0.8 34.8 23 .8 % 44.5 % 53 .9 % 32.3% ... 1 7 .0 % 36.4% EBITDA as per Result Add : a) Other i ncome s
44.5 %
14.4% 27 .7 -1.0 -1.2 25.5 26.9 19.3 1.6 47.8 15.7% 32.4 3 .2 -0.8 34.8 23 .8 % 44.5 % 53 .9 % 32.3% ... 1 7 .0 % 36.4% EBITDA as per Result Add : a) Other i ncome shown i n
Speaking time
BOROS II
21
Add
1
BOROSit
1
BOROS It
1
Advertisement
Opening remarks
BOROS II
.• · · ' Brdnd:<wifh a- = -=- . . . . .• . .. Market Leader in . • . . •. . . .. ··. Laboratory ,~los-swore .. : i'h· t:ndi~ = ($cienttfic & . Industrial Product$) 2 SIP - Labware - Klasspack Total SIP Consu merware - BGWL - Larah Total Consumerware 154.3 41.7 196.0 203.1 146.9 350.0 68.7 21.4 90.1 90.4 69.9 160.3 75.1 21.0 96.1 133.5 74.0 207.5 , , , 9.4% -2.3% 6.6% 47.7% 5.8% 29.4%
BOROS II
EBITDA from OQerations - BGWL * - Larah - Klasspack 51.0 26.7 2.7 80.3 14.7% PAT (Including Income from Investments} 57 .7 - BGWL -3 .3 - Larah -1.8 - Klasspack 52.7 21.7 13.4 1.0 36.1 14.4% 27 .7 -1.0 -1.2 25.5 26.9 19.3 1.6 47.8 15.7% 32.4 3 .2 -0.8 34.8 23 .8 % 44.5 % 53 .9 % 32.3% ... 1 7 .0 % 36.4% EBITDA as per Result
Add
a) Other i ncome shown i n the r esults includes operational income as well {Interest on overdue Debtors, Loans , Deposits and export incentives etc.) b) Other e x penses includes expenses related to other income as well. 20.3 4.4 2 .2 4 Total Market Size Market Growth % (Crs.) 100 440 700 500 400 (incl. ceramicware) 9000 10% 10% 15% to 20% 20% 15% 10% .. I ~ -,.. 7 BOROSIL® 8 I ' CURRENT TAILWIND http :/J-w.n,yborosil.c:om botosil L-baroail.com 12 ,,, Walmart ~., Save money. Live better. HomeTownF D-=- Mart Home Stop lor your kind of homo Llfestyle more. SPAR HyperCITY I J. Big store. Big savings. @ BOSCH .... .... ALKI:N ~ /"") Whirlpool • Panasonic ideas for life ~OCKHAI?DT ~~ 1pca I-ICL ®
BOROS II
Product range • Beakers Test Tubes • Conical Flasks • Bottles Volumetric Flasks • Pipettes • Burettes • Petri Dishes Cylinders ~ ~I -- • Condensers • Desiccators Round Bottom Flask BOROSIL® 18
BOROS II
Cipla Clll'tuSJIII' Iiji• [Ill] Mylan Seein g is believing * PHARMACEUTICAlS, INC. .~. LUPIN ,--• DR.REDDY'S RANBAXY LABORATORIES LIMITED G qlenma~k t\ lh.' W w .ty fnr a nc.·w wnrld 'lt~'Zd TEVA PHARMACEUTICALS 24 BOROS I~ 25 Sales (INR Cr.) Operating EBITDA (INR Cr.) 1 135 12 4 546 80 26% "37%
BOROS II
Revenue From Operations 216.8 105.7 101.7 -3.8% Depreciation & Amortization Profit Before Tax Profit After Tax 13.3 17.9 14.2 10.0 45.4 26.6 8.9 7.1 -66.6% 0.3% 11.0 -23.4% 7.1 8.9 10.6 -9.2 -186.4% 8.6 -6.6 -177.2%
Advertisement
← All transcriptsBORORENEW stock page →